Main
>
ENDOCRINOLOGY
>
Diabetes. Treatment
>
Insulin.
>
Insulin>Human>Rapid Acting Inj.
>
Co.: USA. B. (Phase III/Patent)
>
Patent>USA Expiration: 01.2026
Patent>USA Expiration: 01.2026's products
This section has no products